LYW2402-NS-HK

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameLYW2402-NS-HK
Drug Alias NameLYW2402-NS-HK人源基质细胞注射液(三维工艺制备)LYW2402-NS-HK
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesLiaoning Medical Diagnosis and Treatment Technology Research and Development Center Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLiaoning Medical Diagnosis and Treatment Technology Research and Development Center Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A